Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Why this one
GLP1-SEMA is a synthetic peptide engineered to interact with glucagon-like peptide-1 (GLP-1) receptors
These findings underscore that GLP-1 therapy is a long-term intervention rather than a short-term solution
Vesugen: A vascular-supportive peptide associated in research settings with maintaining endothelial integrity and microcirculatory balance
doi: 10.3389/fimmu.2024.1440313 Received 30 May 2024 Accepted 18 November 2024 Published 05 December 2024 Volume 15 - 2024 Edited by Xing Wang, The Affiliated Hospital of Southwest Medical University, China Reviewed by Christoph Hudemann, Philipps-University Marburg, Germany Franziska Roth-Walter, University of Veterinary Medicine Vienna, Austria Updates Copyright 2024 Biedrzycki, Wolszczak-Biedrzycka, Dorf and Maciejczyk
Efficacy and safety of lixisenatide once-daily versus exenatide twice-daily in patients with type 2 diabetes insufficiently controlled on metformin (GetGoal-X) [abstract 786]
